About This Project

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company developing immunotherapies based on Chimeric Antigen Receptor (CAR) research. To achieve its goals of treating cancer, Mustang Bio, a Fortress Biotech Company, has expanded its clinical stage production capabilities.

Project Scope

This is a 29,500 sq ft level facility comprising laboratories, offices, and utility areas. This project focused on fitting out ~12,000 sq ft upgrading existing office and labs therein, and converting approximately 4,900 sq ft of existing labs to four cGMP ISO7 production areas.